Michael Kozik1,2,3, Nino Isakadze1,2,3,4, Seth S Martin1,2,3,4. 1. Department of Medicine, Division of Cardiology. 2. Ciccarone Center for the Prevention of Cardiovascular Disease, Digital Health Innovation Laboratory, Johns Hopkins University School of Medicine. 3. Johns Hopkins Center for Mobile Technologies to Achieve Equity in Cardiovascular Health (mTECH). 4. Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Abstract
PURPOSE OF REVIEW: Despite cutting edge acute interventions and growing preventive strategies supported by robust clinical trials, cardiovascular disease (CVD) has stubbornly persisted as a leading cause of death in the United States and globally. The American Heart Association recognizes mobile health technologies (mHealth) as an emerging strategy in the mitigation of CVD risk factors, with significant potential for improving population health. The purpose of this review is to highlight and summarize the latest available literature on mHealth applications and provide perspective on future directions and barriers to implementation. RECENT FINDINGS: While available randomized controlled trials and systematic reviews tend to support efficacy of mHealth, published literature includes heterogenous approaches to similar problems with inconsistent results. Some of the strongest recent evidence has been focused on the use of wearables in arrhythmia detection. Systematic reviews of mHealth approaches demonstrate benefit when applied to risk factor modification in diabetes, cigarette smoking cessation, and physical activity/weight loss, while also showing promise in multi risk factor modification via cardiac rehabilitation. SUMMARY: Evidence supports efficacy of mHealth in a variety of applications for CVD prevention and management, but continued work is needed for further validation and scaling. Future directions will focus on platform optimization, data and sensor consolidation, and clinical workflow integration. Barriers include application heterogeneity, lack of reimbursement structures, and inequitable access to technology. Policies to promote access to technology will be critical to evidence-based mHealth technologies reaching diverse populations and advancing health equity.
PURPOSE OF REVIEW: Despite cutting edge acute interventions and growing preventive strategies supported by robust clinical trials, cardiovascular disease (CVD) has stubbornly persisted as a leading cause of death in the United States and globally. The American Heart Association recognizes mobile health technologies (mHealth) as an emerging strategy in the mitigation of CVD risk factors, with significant potential for improving population health. The purpose of this review is to highlight and summarize the latest available literature on mHealth applications and provide perspective on future directions and barriers to implementation. RECENT FINDINGS: While available randomized controlled trials and systematic reviews tend to support efficacy of mHealth, published literature includes heterogenous approaches to similar problems with inconsistent results. Some of the strongest recent evidence has been focused on the use of wearables in arrhythmia detection. Systematic reviews of mHealth approaches demonstrate benefit when applied to risk factor modification in diabetes, cigarette smoking cessation, and physical activity/weight loss, while also showing promise in multi risk factor modification via cardiac rehabilitation. SUMMARY: Evidence supports efficacy of mHealth in a variety of applications for CVD prevention and management, but continued work is needed for further validation and scaling. Future directions will focus on platform optimization, data and sensor consolidation, and clinical workflow integration. Barriers include application heterogeneity, lack of reimbursement structures, and inequitable access to technology. Policies to promote access to technology will be critical to evidence-based mHealth technologies reaching diverse populations and advancing health equity.
Authors: Soumitra S Bhuyan; Ning Lu; Aastha Chandak; Hyunmin Kim; David Wyant; Jay Bhatt; Satish Kedia; Cyril F Chang Journal: J Med Syst Date: 2016-05-04 Impact factor: 4.460
Authors: Brian G Danaher; Milagra S Tyler; Ryann C Crowley; Håvar Brendryen; John R Seeley Journal: J Med Internet Res Date: 2019-06-06 Impact factor: 5.428
Authors: Reshmi J S Patel; Jie Ding; Francoise A Marvel; Rongzi Shan; Timothy B Plante; Michael J Blaha; Wendy S Post; Seth S Martin Journal: J Am Heart Assoc Date: 2022-09-03 Impact factor: 6.106